Chaperokine Fingerprint Lot-Release Assay for Recombinant Hsp70

A cell-based QC service that decomposes a recombinant Hsp70 lot's immune-stimulating activity across its known surface receptors (TLR2/4-CD14, CD36, CD91, LOX-1, SR-A, CD40), so reagent suppliers and HSP-therapy developers can certify potency and receptor specificity lot-to-lot.